- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04058301
Text-Enabled Ascertainment and Community Linkage for Health (TEACH)
January 23, 2023 updated by: Margaret Samuels-Kalow, Massachusetts General Hospital
The goal of this study is to pilot test a novel tool for health related social needs screening and linkage to community resources in the ED by randomizing participants to standard handout v. handout + text message with resource information.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 51 ZIP codes included in our database of community resources ("catchment area")
- >=18 years old
- plan for discharge home
- speak either English or Spanish
- live within the catchment area for the study
- have a cellphone with text messaging capabilities
- ability to respond to text messages from the study team.
Exclusion Criteria:
- Patients who are intoxicated
- on a Section 12
- lack capacity to consent will be excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Handout
Participants receive a generic handout about resources in Boston
|
|
Experimental: Text message
Participants receive a generic handout about resources in Boston and a text message with a geographically proximate resource
|
Geographically proximate resources delivered by text message
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Satisfaction: Likert scale
Time Frame: 3-5 days
|
Participants will be asked about their satisfaction with the program measured on a Likart scale.
Options will include "Extremely or Quite a bit; Somewhat; A little bit or Not at all"
|
3-5 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Resource use
Time Frame: 3-5 days
|
Participants will be asked about actual and planned resource use
|
3-5 days
|
Health status
Time Frame: 3-5 days
|
Participants will be asked about health status.
In general, how would you rate your health?
Excellent, Very good, Good or Fair,Poor
|
3-5 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ED utilization
Time Frame: 30 days
|
Chart review of ED visits and potentially preventable utilization
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 9, 2019
Primary Completion (Actual)
March 1, 2020
Study Completion (Actual)
March 1, 2020
Study Registration Dates
First Submitted
May 17, 2019
First Submitted That Met QC Criteria
August 14, 2019
First Posted (Actual)
August 15, 2019
Study Record Updates
Last Update Posted (Actual)
January 25, 2023
Last Update Submitted That Met QC Criteria
January 23, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019P001579
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Emergency Medicine
-
Samsung Medical CenterRecruitingEmergency Medicine | Medical Informatics | Pediatric Emergency MedicineKorea, Republic of
-
RWTH Aachen UniversityCompletedTelemedicine | Disaster Medicine | Emergency MedicineGermany
-
Washington University School of MedicineEpharmix, Inc.CompletedEmergency Medicine | Mobile Health | General MedicineUnited States
-
Mario Negri Institute for Pharmacological ResearchCentre Hospitalier Universitaire Vaudois; Fondazione Bruno Kessler; Astir S.r.l. and other collaboratorsNot yet recruiting
-
Guangdong Provincial People's HospitalRecruiting
-
Ataturk UniversityCompletedEmergency MedicineTurkey
-
Mario Negri Institute for Pharmacological ResearchFondazione Bruno Kessler; Astir S.r.l.; Orobix Life S.r.l.Not yet recruiting
-
University of AarhusAarhus University Hospital; Herning Hospital; Horsens Hospital; Randers Regional... and other collaboratorsCompleted
-
Sheba Medical CenterDr. Yahel Giat; Pr. Merav Lidar; Dr. Michael Dreyfuss; Dr. Avinoah Irony; Dr. Gabrieal...CompletedEMERGENCY MEDICINE
Clinical Trials on Text message information
-
Mayo ClinicAdelante HealthcareCompleted
-
University of California, San FranciscoUniversity of WashingtonCompleted
-
University of WashingtonUniversity of Illinois at Chicago; Kenya Medical Research InstituteCompletedHIV Infections | Acquired Immunodeficiency Syndrome | Circumcision, Male | Patient Compliance | Cellular PhoneKenya
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Texas Tech University Health Sciences CenterTexas Tech UniversityCompletedBreast Cancer FemaleUnited States
-
University of WashingtonUniversity of California, San Francisco; Kenya Medical Research InstituteCompletedHIV Infections | Acquired Immunodeficiency SyndromeKenya
-
Wake Forest University Health SciencesCompleted
-
New York City Health and Hospitals CorporationWithdrawn
-
University of PittsburghCompleted
-
Jonsson Comprehensive Cancer CentereHealth International, INC.RecruitingObesity | Malignant NeoplasmUnited States